Atossa Therapeutics, Inc. - Common Stock (NQ:ATOS)
0.7748
+0.0228
(+3.03%)
Streaming Delayed Price
Updated: 1:12 PM EST, Nov 21, 2025
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
MicroMarvel - Atossa Therapeutics ↗
April 06, 2024
Earnings Scheduled For March 25, 2025 ↗
March 25, 2025
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday ↗
September 11, 2024
ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q2 2024 ↗
August 12, 2024
12 Health Care Stocks Moving In Friday's After-Market Session ↗
September 08, 2023
12 Health Care Stocks Moving In Friday's Intraday Session ↗
September 08, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023 ↗
September 08, 2023
Frequently Asked QuestionsIs Atossa Therapeutics, Inc. - Common Stock publicly traded?
Yes, Atossa Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Atossa Therapeutics, Inc. - Common Stock trade on?
Atossa Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Atossa Therapeutics, Inc. - Common Stock?
The ticker symbol for Atossa Therapeutics, Inc. - Common Stock is ATOS on the Nasdaq Stock Market
What is the current price of Atossa Therapeutics, Inc. - Common Stock?
The current price of Atossa Therapeutics, Inc. - Common Stock is 0.7748
When was Atossa Therapeutics, Inc. - Common Stock last traded?
The last trade of Atossa Therapeutics, Inc. - Common Stock was at 11/21/25 01:12 PM ET
What is the market capitalization of Atossa Therapeutics, Inc. - Common Stock?
The market capitalization of Atossa Therapeutics, Inc. - Common Stock is 97.46M
How many shares of Atossa Therapeutics, Inc. - Common Stock are outstanding?
Atossa Therapeutics, Inc. - Common Stock has 97M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|